The Japanese Journal of Neuro-ophthalmology (Shinkei Ganka) accepts original papers (case reports and short communication) on clinical and/or basic investigations of neuro-ophthalmology. The special topics, review and others are also published in the journal according to discretion of the editorial meeting.
Submitted manuscript (to the Asian section) must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere. The first or senior author(s) should belong to Asian Neuro-ophthalmology Society (ASNOS). All authors must sign “Authorship Responsibility, Copyright Transfer” form and submit it with the original manuscript. All accepted manuscripts, artwork, and photographs become the property of the publisher.
The manuscript must be written in scientifically correct English as a Microsoft Word document. All parts of the manuscript should be typewritten, double-spaced, with margins of at least one inch on all sides. Number manuscript pages consecutively throughout the paper beginning with the title page. Tables and figures should be submitted as separate files. The manuscript should be submitted to ASNOS office by e-mail to:
Accepted manuscript will be opened at an electronic journal site called J-STAGE (https://www.jstage.jst.go.jp/browse/-char/ja/) administered by Japan Science and Technology Agency.
The title page should contain the article title, full name(s) of author(s), highest academic degrees, department(s), institution and the address, e-mail address, telephone and fax numbers of the corresponding author, a running title of not more than 40 characters. Include the address for reprints if different from that of corresponding author.
Abstract should be provided that clearly describes the manuscript in no more than 250 words. Japanese abstract will be added in editorial office in the case of acceptance.
Key words are required for indexing and abstracting services up to 5 words.
All manuscripts must be organized into Introduction, Materials and Methods, Results, Discussion. Abbreviations must be defined immediately following the first appearance in the text. Drug and chemical names should be stated in standard chemical or generic nomenclature. Units of measure should be presented according to the International System of units (SI). Clinical data may be presented in conventional units with SI in parentheses.
Acknowledgement should be included at the end of the text. If data from other published studies are used, it is the author’s responsibility to obtain permission.
The authors are responsible for the accuracy of the references. References should be numbered consecutively in text in the order of appearance. If there are more than two authors, name only the first two authors and then use et al. Refer to the List of Journal Indexed in Index Medicus - abbreviations of journal titles.
Tables must be submitted in Microsoft Excel or Word document, cited in order in the text, and numbered consecutively with Arabic numerals. Each table should have a caption typed above the table. Table footnotes should be indicated by superscript lower-case letters.
Figures must be submitted in DOC(X), XLS(X), PPT(X), JPG, TIFF files, cited consecutively in the text, and numbered in the order in which they are discussed with Arabic numerals. Brief legends for each figure should be typed on separate pages. Figures must be of sufficient size and clarity to allow reduction as necessary to meet layout requirements. Letters, numbers, symbols in a figure should be clear and of sufficient size so that if the figure must be reduced for publication they will still be legible. Authors are charged for color figures, tracing and reprints.
Page proofs and corrections:
Corresponding authors will receive page proofs to check the copyedited and typeset article before publication. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to make the article conform to journal style should be allowed to stand unless they alter the authors’ meaning. Proofs must be checked carefully and returned within 2 days of receipt, as requested in the cover letter accompanying the page proofs.
Authors will receive a reprint order form with the page proofs that includes reprint costs. Reprint requests should be returned with the corrected proofs. Reprints are normally shipped within 2 months after publication of the issue in which the item appears.
Patient anonymity and informed consent:
It is the author’s responsibility to make sure that a patient’s anonymity is protected accurately. Authors should remove patients’ names from figures unless they obtain written consent from the patients and submit the written consent with the manuscript. It is also the author’s responsibility to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated.
Declaration of Helsinki:
For research involving human subjects, ASNOS requires that authors state that their research followed the tenets of the Declaration of Helsinki in the Methods section of their manuscript.
To submit the manuscripts and to send corrected page proofs, reprint order forms, and any other inqueries, contact the following: